# Phase E final report

## PHASE

Phase E — Independent Prescription Validation Engine

## STATUS

COMPLETE

## ARCHITECTURE / INDEPENDENCE

Added framework-free `@formation-zero/validation-engine`. Its manifest and source do not depend on or import `@formation-zero/prescription-engine`; an automated boundary test enforces this. Phase E owns inspection schemas, independent arithmetic/composition, findings, fingerprints and deterministic material. It calls only Phase C `evaluate` for an authoritative fresh rule decision. ADR 0016 records the boundary.

## VALIDATION MODEL

`PASS` has no findings. `WARN` contains only policy-approved nonblocking codes. `REJECT` contains a block or unapproved warning. Stable version-1 ACTIVE codes include public-safe and restricted explanations across all required categories. No client status is accepted.

## SAFETY / RULE RECHECK

Every selected content/dose pair is independently reevaluated through Phase C with exact rules, versions, date and supplied facts. Blocks, intensity/complexity caps, recovery requirements, functional restrictions and policy reasons map to blocking Phase E findings.

## CONTENT / RIGHTS

Production evidence is loaded from PostgreSQL at validation and delivery. Exact template/content status, production eligibility, current version, required reviews, rights classification/commercial permission, transitive sources and media remain server-owned. Actual pending B2 content is rejected and remains unpublished.

## DOSE / TIME

Dose identity/profile, interfaces, floors, ranges and minimum rest are checked. Work/rest/setup/transition/item/section/buffer/total/unused arithmetic is independently recalculated without Phase D timing code.

## COMPOSITION / DEMAND

Required/optional slots, unique slots/content, reviewed slot matching, section order, preparation linkage and explicit Phase C work-second demand caps are checked.

## EQUIPMENT / ENVIRONMENT

Required equipment must be supplied and not unsafe. Limited-space and supplied environment tags are checked independently.

## READINESS / LOAD / PHASE

Phase E validates effects of supplied values through Phase C; it does not calculate readiness, load or program phase. YELLOW, ORANGE, RED recovery and load/phase mutation cases are covered.

## OBJECTIVE / RELATIONSHIPS / SUPERVISION

Request/template/session/slot/dose objective alignment, exact relationship direction/target, reviewed slot basis and supervision requirements are checked. A valid synthetic substitution passes.

## PROVENANCE / TAMPER

Exact engine/rule-set/rule/reason/knowledge/template/content/date references are checked. Domain-separated HMACs cover request, exact construction input, final prescription artifact and history input. Construction context is stored in an AES-256-GCM envelope. Request/artifact/version mutations reject.

## EXPLAINABILITY / CONTRADICTIONS

The public rationale must match the candidate state and remain free of supplied sensitive strings. A selected item contradicted by Phase D's restricted base trace rejects. Public summaries remain fixed and generic.

## DELIVERY GATE

Production delivery requires Phase D success, a latest stored Phase E PASS/approved WARN under the active policy, and a fresh Phase E recheck with current upstream evidence. Test prescriptions, missing validation, rejects, stale policies and superseded content are denied. The client cannot choose policy or status.

## ADVERSARIAL SCENARIOS

All 30 directive-numbered mutations pass: each returns REJECT with its expected stable code. The admin can inspect the 30-scenario fixture catalog. API tests separately cover actual B2, post-validation content supersession, forged PASS and forged policy fields.

## GOLDEN SCENARIOS

Clean PASS, approved WARN, deterministic repeat, shuffled construction input, valid substitution, YELLOW, ORANGE, RED recovery-only, no-session/no-safe and production delivery/invalidation scenarios pass.

## IMMUTABLE HISTORY

Migration 008 adds immutable validation policies, activation history and prescription validation history. Update/delete/truncate triggers and runtime SELECT/INSERT grants are tested. Exact historical results remain actor-scoped.

## ADMIN / API

Authenticated internal endpoints cover fixture catalog, validation, validation retrieval, policy list/create/activate/history and delivery eligibility. The existing no-store allowlisted Next proxy and admin prescription console expose synthetic validation/history controls. Ordinary USER access is denied. No consumer delivery UI exists.

## SECURITY / PRIVACY

Strict schemas, existing origin/session controls, least privilege, parameterized SQL, 16 KB body limit, safe errors, actor isolation, encrypted exact inputs, keyed fingerprints, fixed public summaries and restricted traces are implemented. Sensitive markers do not appear in API history, ciphertext checks or generic logs. No B2 state was promoted and no review/rights record was fabricated.

## DATABASE / FILES / ADRS

Migration: `008_validation_engine.sql` adds sealed prescription input/fingerprint columns and immutable policy/activation/result tables. Created the validation package, validation service/crypto helper, Phase E test, nine focused validation/delivery documents, plan, report and ADR 0016. Modified prescription persistence, API routes, runtime grants, admin proxy/console, workflow label, smoke/regression tests, architecture/security/privacy/testing/changelog and workspace lockfile.

## TESTS / RESULTS

- Local migrations: migration 008 applied; rerunnable seed passed; corpus import remained exactly 100 exercise, 30 recovery, 16 equipment, 100 media requirements and zero production media.
- Full automated suite: 136 tests passed, 0 failed; includes 30/30 adversarial mutations.
- Final clean source-only validation at `2026-09-05T13:56:26.942Z`: install, all migrations, seed, corpus, full 136-test validation and failure probes each exited 0. A focused 36-test validator/API run also passed.
- The complete clean validation pipeline was repeated successfully after the Phase E fast-forward merge on `main` at `1b8dd2b5cc9dacc9e7582028a4fc42e1cc6441a0`; install, migrations, seed, corpus, validation and failure probes each exited 0.
- Format, ESLint, strict TypeScript, secret/client scans, runtime grants and failure probes passed.
- Dependency audit: 0 vulnerabilities. License inventory: 828 locked entries reviewed, no unresolved licenses.

## BUILD RESULTS

Web and admin Next.js production builds passed. API ESM build passed (173.85 KB). Expo web/Android/iOS exports passed; Expo Doctor passed 21/21; mobile permission check passed. Built API/web/admin/CMS smoke passed, including Phase E validation/history, 30-fixture catalog, test delivery denial and anonymous denial.

## HOSTED CI

GitHub Actions workflow `Phase A foundation`, run [33970392758](https://github.com/stevendecker1986/formation-zero/actions/runs/33970392758), completed successfully for branch `codex/phase-e-validation-engine` at exact implementation commit `cd3b905831cc9cecd9d7ba39a882b79838b430c2`.

The validated feature branch was fast-forwarded into `main` without rewriting history. GitHub Actions workflow `Phase A foundation`, run [33972082558](https://github.com/stevendecker1986/formation-zero/actions/runs/33972082558), completed successfully for the exact merged main commit `1b8dd2b5cc9dacc9e7582028a4fc42e1cc6441a0`; its `validate` job completed successfully.

## ACCEPTANCE CRITERIA

PASS — every Phase E acceptance criterion passes with the implementation, clean validation and hosted evidence above. Earlier phases remain green; the validator is independent; all gates, mutations, golden scenarios, security/privacy checks, builds and documentation pass. Phase F and consumer workout UI are absent.

## KNOWN ISSUES

Existing prescriptions created before migration 008 have no sealed validation context and fail closed with `VALIDATION_INPUT_UNAVAILABLE`. No production validation policy is seeded or activated; an authorized publisher must create and activate a reviewed production policy before real production validation. These are intentional safety boundaries.

## OPEN DECISIONS

Production retention/deletion policy for health-adjacent validation inputs/history and the first authorized production validation-policy content remain owner decisions before commercial use.

## PHASE F READINESS

READY. Phase E is complete; Phase F has not begun and requires separate authorization.
